What one share of Teva Pharmaceutical Industries Limited holds
We are a biopharmaceutical company, enabled by a world-class generics business. For over 120 years, our commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, we are dedicated to addressing patients’ needs, now and in the future.
Teva Pharmaceutical Industries Limited’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $14.88 |
|---|---|
| Profit | $0.61 |
| Capex (buildings and equipment) | $0.47 |
| Free cash flow | $1.16 |
| Cash and investments | $3.14 |
| Debt | $14.29 |
| Book value | $6.65 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2007 | $11.33 | $2.31 | $0.65 | $1.53 | — | $18.05 |
| 2008 | $13.52 | $0.75 | $0.83 | $3.11 | $0.50 | $18.42 |
| 2009 | $17.99 | $2.23 | $0.80 | $2.96 | $0.61 | $20.83 |
| 2010 | $17.50 | $3.66 | $0.77 | $3.72 | $0.74 | $23.42 |
| 2011 | $20.51 | $3.09 | $1.18 | $3.45 | $0.89 | $25.14 |
| 2012 | $23.27 | $2.25 | $1.26 | $3.97 | $1.03 | $26.57 |
| 2013 | $23.90 | $1.49 | $1.21 | $2.60 | $1.28 | $26.61 |
| 2014 | $23.63 | $3.56 | $1.08 | $4.89 | $1.34 | $27.36 |
| 2015 | $22.75 | $1.82 | $0.89 | $5.52 | $1.36 | $29.16 |
| 2016 | $22.79 | $0.07 | $0.94 | $3.11 | $1.36 | $26.45 |
| 2017 | $21.51 | −$16.26 | $0.86 | $1.33 | $0.85 | $13.50 |
| 2018 | $17.90 | −$2.35 | $0.64 | $1.76 | $0.00 | $13.49 |
| 2019 | $15.48 | −$0.92 | $0.48 | $0.20 | $0.00 | $12.79 |
| 2020 | $15.21 | −$3.64 | $0.53 | $0.58 | — | $9.15 |
| 2021 | $14.34 | $0.38 | $0.51 | $0.21 | — | $9.32 |
| 2022 | $13.45 | −$2.20 | $0.49 | $0.94 | — | $7.02 |
| 2023 | $14.16 | −$0.50 | $0.47 | $0.75 | — | $6.70 |
| 2024 | $14.63 | −$1.45 | $0.44 | $0.66 | — | $4.74 |
| 2025 | $14.84 | $1.21 | $0.43 | $0.99 | — | $6.88 |
Common questions about Teva Pharmaceutical Industries Limited
How much does one share of Teva Pharmaceutical Industries Limited earn?
Over the last 12 months, each share of Teva Pharmaceutical Industries Limited earned $0.61 of profit on $14.88 of sales, keeping about 4¢ of every $1 (profit margin).
Does Teva Pharmaceutical Industries Limited pay a dividend?
Teva Pharmaceutical Industries Limited didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Teva Pharmaceutical Industries Limited’s book value per share?
Teva Pharmaceutical Industries Limited’s book value is $6.65 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Teva Pharmaceutical Industries Limited have?
Each share of Teva Pharmaceutical Industries Limited has $3.14 of cash and investments and $14.29 of debt, as of June 30, 2026.
What is Teva Pharmaceutical Industries Limited’s free cash flow per share?
$1.16 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Teva Pharmaceutical Industries Limited’s profit per share changed over time?
Profit per share went from $2.31 in 2007 to $1.21 in 2025, shrinking about 3.5% a year (adjusted for stock splits).
Has Teva Pharmaceutical Industries Limited bought back shares?
Teva Pharmaceutical Industries Limited’s share count rose about 40% from 2007 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.